This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Uhlmann Pac-Systeme Gmbh & Co Kg. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Sven Kuhnert: Innovator in Pharmaceutical Chemistry
Introduction
Sven Kuhnert is a notable inventor in the field of pharmaceutical chemistry, based in Germany. He has made significant contributions to the development of innovative compounds aimed at improving medical treatments, particularly in pain management. His work is characterized by a focus on unique chemical structures that have potential therapeutic applications.
Latest Patents
Sven Kuhnert holds several patents, including the following notable inventions:
1. **3-((hetero-)aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives** - This invention relates to compounds designed for use in medicine, particularly for the treatment of pain.
2. **3-(carboxyethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives** - Similar to the previous patent, this invention focuses on compounds that can be utilized in medical applications, especially in pain management.
Career Highlights
Sven Kuhnert is currently employed at Grünenthal GmbH, a company renowned for its commitment to developing innovative pain management solutions. His work at Grünenthal has allowed him to explore and develop new chemical entities that can significantly impact patient care.
Collaborations
Throughout his career, Sven has collaborated with several talented individuals, including Rene Michael Koenigs and Florian Jakob. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.
Conclusion
Sven Kuhnert is a dedicated inventor whose work in pharmaceutical chemistry has the potential to transform pain management therapies. His innovative approach and collaboration with other experts in the field highlight his commitment to advancing medical science.